Scope of the Study
Data visualization is an integral part of biological sciences and essential to enable dissemination of knowledge and sophisticated analysis of data. With advances in both biological data acquisition technologies and data-management and -processing technologies, researchers face challenges of developing better conjectures from the data that continue to increase in volume and complexity. The goal of biological data visualization is to support the development of analysis methods and the interpretation of results, encompassing both engineering and scientific research challenges.
The market study is being classified, by Application (Cell and Organism Imaging, Structural Biology and Molecular Modeling, Genomic Analysis, Alignments, Phylogeny, and Evolution and Systems Biology) and major geographies with country level break-up.
3M Company (United States), Thermo Fisher Scientific, Inc. (United States), Agilent Technologies, Inc. (United States), QIAGEN (Germany), Becton, Dickinson and Company (United States), Carl Zeiss (Germany), Olympus Corporation (Japan), Oxford Instruments plc (United Kingdom), Genedata AG (Switzerland), Clarivate (United States), Arivis AG (Germany) and Danaher Corporation (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Genialis, Inc. (United States), Scientific Volume Imaging B.V. (Netherlands), Media Cybernetics, Inc. (United States), Molecular Devices, LLC (United States), Plotly (Canada) and Advanced Visual Systems, Inc. (Canada).
AdvanceMarketAnalytics has segmented the market of Global Biological Data Visualization market by Type, Application and Region.
On the basis of geography, the market of Biological Data Visualization has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Cloud Deployment of Data Visualization Solutions
- Need for Quick Decision Making
- Demand for Image-Processing Integrated With Artificial Intelligence
- Lack of Computational Consistency
- Advent of Virtual Reality Environment
- Growth of Biological Data
- Lack of Technically Skilled Workforce
In July 2019, Olympus Corporation introduced scanR 3.1 High-content Screening Station (HCS), a modular microscope-based imaging platform. This platform uses artificial intelligence technology for the analysis of live cells and provide fully automated image acquisition and data analysis of biological samples.
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Biological Data Visualization Providers, Technology Service Providers, Venture Capitalists and Private Equity Firms and Government Regulatory and Research Organizations
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase